🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicentre Phase Ib study to evaluate the safety an...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-04-10
Trial ID
NCT06251180
Treatments Being Tested
This is a Phase 3, randomized, open-label, multicenter study comparing rocb...
Status
Recruiting
Location
Orchard Healthcare Research
Start Date
2026-04-23
Trial ID
NCT07342478
Treatments Being Tested
This is an open-label, randomized controlled, multicenter Phase II clinical...
Status
Recruiting
Location
Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital)
Start Date
2025-11-27
Trial ID
NCT07189065
Treatments Being Tested
BTK inhibitors and BCL-2 inhibitors have demonstrated significant clinical ...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2026-07-14
Trial ID
NCT07609862
Treatments Being Tested
This is a multicenter, open-label phase Ib study, evaluating the safety, to...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-05-30
Trial ID
NCT07570017
Treatments Being Tested
Mantle cell lymphoma (MCL) is an aggressive yet often indolent type of B-ce...
Status
Recruiting
Location
Beijing Cancer hospital
Start Date
2026-02-05
Trial ID
NCT07377578
Treatments Being Tested
This is a phase I, open-label, two-part, fixed-sequence drug interaction st...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2026-03-05
Trial ID
NCT07374224
Treatments Being Tested
This is an open-label, single arm, multi-center Phase 2 study of oral Rocbr...
Status
Active Not Recruiting
Location
Anhui provincial cancer hospital
Start Date
2023-02-21
Trial ID
NCT05716087
Treatments Being Tested
This is a randomized, controlled, multicenter, open-label Phase IIa clinica...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-08
Trial ID
NCT07776743
Treatments Being Tested